Cargando…

Phase I dose-escalation study to determine the safety, tolerability, preliminary efficacy and pharmacokinetics of an intratumoral injection of tigilanol tiglate (EBC-46)

BACKGROUND: Tigilanol tiglate, a short-chain diterpene ester, is being developed as intratumoral treatment of a broad range of cancers. We conducted the first-in-human study of intratumoral tigilanol tiglate in patients with solid tumors. METHODS: Tigilanol tiglate was administered in a multicentre,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Panizza, Benedict J., de Souza, Paul, Cooper, Adam, Roohullah, Aflah, Karapetis, Christos S., Lickliter, Jason D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921293/ https://www.ncbi.nlm.nih.gov/pubmed/31810818 http://dx.doi.org/10.1016/j.ebiom.2019.11.037

Ejemplares similares

Randomized controlled clinical study evaluating the efficacy and safety of intratumoral treatment of canine mast cell tumors with tigilanol tiglate (EBC‐46)
por: De Ridder, Thomas R., et al.
Publicado: (2020)

Dose Characterization of the Investigational Anticancer Drug Tigilanol Tiglate (EBC-46) in the Local Treatment of Canine Mast Cell Tumors
por: Miller, Jane, et al.
Publicado: (2019)

Use of the Intratumoural Anticancer Drug Tigilanol Tiglate in Two Horses
por: De Ridder, Thomas, et al.
Publicado: (2020)

Identification of Gene Biomarkers for Tigilanol Tiglate Content in Fontainea picrosperma
por: Mitu, Shahida A, et al.
Publicado: (2022)

Activation of PKC supports the anticancer activity of tigilanol tiglate and related epoxytiglianes
por: Cullen, Jason K., et al.
Publicado: (2021)

Recurrence‐free interval 12 months after local treatment of mast cell tumors in dogs using intratumoral injection of tigilanol tiglate
por: Jones, Pamela D., et al.
Publicado: (2020)

Wound formation, wound size, and progression of wound healing after intratumoral treatment of mast cell tumors in dogs with tigilanol tiglate
por: Reddell, Paul, et al.
Publicado: (2021)

Treatment of multiple synchronous canine mast cell tumours using intratumoural tigilanol tiglate
por: Brown, Graham K., et al.
Publicado: (2022)

Intratumoural Treatment of 18 Cytologically Diagnosed Canine High-Grade Mast Cell Tumours With Tigilanol Tiglate
por: Brown, Graham K., et al.
Publicado: (2021)

Progressive cutaneous viral pigmented plaques in three Hungarian Vizslas and the response of lesions to topical tigilanol tiglate gel
por: Hansen, Naomi, et al.
Publicado: (2017)

Tigilanol Tiglate-Mediated Margins: A Comparison With Surgical Margins in Successful Treatment of Canine Mast Cell Tumours
por: De Ridder, Thomas, et al.
Publicado: (2021)

Intra-Lesional Injection of the Novel PKC Activator EBC-46 Rapidly Ablates Tumors in Mouse Models
por: Boyle, Glen M., et al.
Publicado: (2014)

EBC Pre-Assembly Last Module
Publicado: (2003)

EBC Cradle + 18 modules Displacement
Publicado: (2003)

EBC Pre-Assembly / Top part Assembly
Publicado: (2003)

Inhibitory Effect and Mechanism on Antiproliferation of Isoatriplicolide Tiglate (PCAC) from Paulownia Coreana
por: Jung, Samil, et al.
Publicado: (2012)

New panel of microsatellite alterations detectable in the EBC for lung cancer prognosis
por: Carpagnano, Giovanna E, et al.
Publicado: (2016)

23255 Devices Engineered to Collect Exhaled Breath Condensate (EBC) and their Applications
por: Schmidt, Alexander J., et al.
Publicado: (2021)

The affect of goserelin on the QoL of women having chemotherapy for EBC: Results from the OPTION trial
por: R, Leonard, et al.
Publicado: (2020)

Epigenetic study of early breast cancer (EBC) based on DNA methylation and gene integration analysis
por: Zhang, Wenshan, et al.
Publicado: (2022)

Robust Guidelines for the Management of HR+ Her2− EBC: Crucial Value of CanAssist Breast
por: Vaid, Ashok, et al.
Publicado: (2022)

A phase I dose-escalation, safety/tolerability, and preliminary efficacy study of the intratumoral administration of GEN0101 in patients with advanced melanoma
por: Kiyohara, Eiji, et al.
Publicado: (2022)

An EBC/Plasma miRNA Signature Discriminates Lung Adenocarcinomas From Pleural Mesothelioma and Healthy Controls
por: Faversani, Alice, et al.
Publicado: (2021)

Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours
por: Lickliter, Jason D., et al.
Publicado: (2021)

Correction: Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours
por: Lickliter, Jason D., et al.
Publicado: (2021)

Reference Ranges of 8-Isoprostane Concentrations in Exhaled Breath Condensate (EBC): A Systematic Review and Meta-Analysis
por: Shoman, Yara, et al.
Publicado: (2020)

Author Correction: Epigenetic study of early breast cancer (EBC) based on DNA methylation and gene integration analysis
por: Zhang, Wenshan, et al.
Publicado: (2022)

Intratumoral Injection of (188)Re labeled Cationic Polyethylenimine Conjugates: A Preliminary Report
por: Kim, Eun-Mi, et al.
Publicado: (2004)

Pharmacokinetics of escalating single‐dose administration of cannabidiol to cats
por: Rozental, Aaron J., et al.
Publicado: (2022)

Applying dynamic contrast enhanced MSOT imaging to intratumoral pharmacokinetic modeling
por: Xiao, Ted G., et al.
Publicado: (2018)

Preclinical and clinical investigation of intratumoral chemotherapy pharmacokinetics in DIPG using gemcitabine
por: Green, Adam L, et al.
Publicado: (2020)

Improved ovarian cancer EMT-CTC isolation by immunomagnetic targeting of epithelial EpCAM and mesenchymal N-cadherin
por: Po, Joseph W, et al.
Publicado: (2018)

Systemic effects of angiogenesis inhibition alter pharmacokinetics and intratumoral delivery of nab-paclitaxel
por: Steins, Anne, et al.
Publicado: (2017)

Pharmacokinetics and Pharmacodynamics of Antibody-Drug Conjugates Administered via Subcutaneous and Intratumoral Routes
por: Chang, Hsuan-Ping, et al.
Publicado: (2023)

Preliminary Investigation of the Safety of Escalating Cannabinoid Doses in Healthy Dogs
por: Vaughn, Dana, et al.
Publicado: (2020)

P279 A patient survey evaluating COVID-19-induced changes in follow-up of patients with EBC: opportunities for enhanced evidence-based practice?
por: Beltran-Bless, A.-A., et al.
Publicado: (2023)

Health-Related Quality of Life during Chemoradiation in Locally Advanced Rectal Cancer: Impacts and Ethnic Disparities
por: Lim, Stephanie Hui-Su, et al.
Publicado: (2019)

Respiratory metabolites in bronchoalveolar lavage fluid (BALF) and exhaled breath condensate (EBC) can differentiate horses affected by severe equine asthma from healthy horses
por: Bazzano, Marilena, et al.
Publicado: (2020)

Comparative Analysis of the Conversion of Mandelonitrile and 2-Phenylpropionitrile by a Large Set of Variants Generated from a Nitrilase Originating from Pseudomonas fluorescens EBC191
por: Stolz, Andreas, et al.
Publicado: (2019)

Safety, Pharmacokinetics, and Drug-Drug Interaction Potential of Intravenous Durlobactam, a β-Lactamase Inhibitor, in Healthy Subjects
por: Lickliter, Jason D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ba4ttd2jcnr67vqg4r5svfj482